TREATMENT OF HAIRY CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE

用 2-氯脱氧腺苷治疗毛细胞白血病

• 批准号: 6275082
• 负责人: Eugene P Orringer
• 金额: $ 1.58万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6275082
• 关键词: chlorodeoxyadenosine; clinical research; clinical trials; drug screening /evaluation; drug tolerance; hairy cell leukemia; human mortality; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer pharmacology; pharmacokinetics

The purpose of this protocol is to make 2-CdA available as a treatment for patients with active hairy cell leukemia who are not eligible to participate in other clinical trials. This protocol will contribute to the determination of toxicity, response rate, time to response, duration of response and survival of patients with hairy cell leukemia who are treated with 2-CdA.

该方案的目的是使2-CdA可作为治疗 对于不符合条件的活动性毛细胞白血病患者， 参与其他临床试验。 该协议将有助于 毒性、缓解率、至缓解时间、持续时间的测定 毛细胞白血病患者的反应和生存率， 用2-CdA处理。